Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients

Jean-Guillaume Dillinger 1 Boris Aleil 2 Saida Cheggour Ygal Benhamou 3 Yannick Béjot 4 Sylvestre Marechaux 5 Aurélien Delluc 6 Laurent Bertoletti 7 Nicolas Lellouche 8
1 Hôpital Lariboisière
2 Biologie et pharmacologie de l'hémostase et de la thrombose
3 Service de Médecine Interne [Rouen]
4 CHU Dijon - Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand
5 Groupement Hospitalier de l'Institut Catholique de Lille
6 GETBO - Groupe d'Etude de la Thrombose de Bretagne Occidentale
7 GRT (EA 3065) - Groupe de recherche sur la thrombose
8 IMRB - Institut Mondor de recherche biomédicale
Document type :
Journal articles
Complete list of metadatas
https://hal.univ-brest.fr/hal-02055852
Contributor : Ghislaine Calvez <>
Submitted on : Monday, March 4, 2019 - 12:12:42 PM
Last modification on : Thursday, November 21, 2019 - 2:30:15 AM

Identifiers

  • HAL Id : hal-02055852, version 1

Collections

UNIV-BREST | IMRB | GETBO | UPEC-UPEM | UNIV-ST-ETIENNE | COMUE-NORMANDIE | UNIROUEN | IBSAM | UNIV-PARIS7 | USPC | UPEC | UDL

Citation

Jean-Guillaume Dillinger, Boris Aleil, Saida Cheggour, Ygal Benhamou, Yannick Béjot, et al.. Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients. Archives of cardiovascular diseases, Elsevier/French Society of Cardiology, 2018, 111 (2), pp.85-94. ⟨hal-02055852⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

43

Contact

CCSD